Table 1.
Distribution of demographic characteristics of groups.
| Group 1 n = 17 (%) |
Group 2 n = 17 (%) |
P | |
|---|---|---|---|
| Age | 56 ± 8.4 | 54 ± 7.4 | NS |
|
| |||
| Gender | |||
| Female | 6 (54.5) | 4 (23.5) | NS |
| Male | 11 (45.5) | 13 (76.5) | |
|
| |||
| BSA | 1.83 ± 0.14 | 1.89 ± 0.16 | NS |
| Body weight | 75 ± 11.3 | 80 ± 12.0 | |
|
| |||
| EF | 57 ± 5.0 | 54 ± 5.2 | NS |
|
| |||
| HT | 4 (23.5) | 7 (41.1) | NS |
| DM | 5 (71.4) | 2 (11.7) | NS |
| COPD | 1 (5.8) | 2 (11.7) | NS |
| Thyroid dysfunction | 2 (11.7) | 0 | NS |
| CVD | 1 (5.8) | 0 | NS |
| Smoking | 2 (11.7) | 5 (71.4) | NS |
|
| |||
| Preoperative drug history | |||
| β-blockers | 3 (17.6) | 3 (17.6) | NS |
| CCBs | 0 | 1 (5.8) | NS |
| Nitrates | 4 (23.5) | 3 (17.6) | NS |
| ACEIs | 3 (17.6) | 3 (17.6) | NS |
|
| |||
| Mortality | — | — | — |
|
| |||
| Complications | — | — | — |
BSA: body surface area, EF: ejection fraction, HT: hypertension, DM: diabetes mellitus, COPD: chronic obstructive pulmonary disease, CVD: cerebrovascular disease, CCB: calcium channel blocker, ACEI: angiotensin converting enzyme inhibitor, and NS: not significant.